Accipiter Biosciences vs Terray Therapeutics
Which Healthcare AI tool is better in 2026?
Accipiter Biosciences
AI-designed de novo protein therapies for complex diseases
Terray Therapeutics
Generative AI and ultra-high-throughput chemistry for small-molecule drug discovery
Side-by-side
Terray Therapeutics is the more established option (raised $180M); pricing is comparable on both sides.
| Metric | Accipiter Biosciences | Terray Therapeutics |
|---|---|---|
| Taglinei | AI-designed de novo protein therapies for complex diseases | Generative AI and ultra-high-throughput chemistry for small-molecule drug discovery |
| Foundedi | 2025 | 2018🏆 |
| HQi | Seattle, United States | Monrovia, US |
| Employeesi | — | 51-200🏆 |
| Neuron scorei | 68 | 74🏆 |
| Total fundingi | $12.7M | $180M🏆 |
| Latest roundi | Seed · Nov 2025 | Series B · Oct 2024 |
| Valuationi | — | — |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✗ | ✗ |
| Free triali | ✗ | ✗ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Custom | Enterprise · Contact sales |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Accipiter Biosciences and Terray Therapeutics.
| Capability | Accipiter Biosciences | Terray Therapeutics |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✗ | ✗ |
| Free trial | ✗ | ✗ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Accipiter Biosciences
- Newer company (2025)
🔵 Strengths of Terray Therapeutics
- Has raised more capital ($180M vs $12.7M)
- Higher Neuron score (74 vs 68)
- More mature (2018)
Which should you choose?
Choose Terray Therapeutics if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Terray Therapeutics if you want the most established option — it has raised $180M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Accipiter Biosciences vs Terray Therapeutics — which is better?
It depends on your priority. Accipiter Biosciences is the leaner option; Terray Therapeutics has broader feature depth. See the side-by-side table above.
Is Accipiter Biosciences cheaper than Terray Therapeutics?
No — Terray Therapeutics's cheapest paid plan is Enterprise · Contact sales, while Accipiter Biosciences's is Custom.
Do Accipiter Biosciences and Terray Therapeutics offer free plans?
Accipiter Biosciences: Paid only. Terray Therapeutics: Paid only.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.